18F-FLT联合18F-FDG诊断高分化肝癌一例  

18F-FLT combined with 18F-FDG in the diagnosis of highly differentiated hepatocellular carcinoma: a case report

作　　者：张威[1] 许国辉[1] 程祝忠[1] 姚玉唐 何发伟 李勇[1] 罗红兵[1] Zhang Wei;Xu Guohui;Cheng Zhuzhong;Yao Yutang;He Fawei;Li Yong;Luo Hongbing(PET/CT Centre, Sichuan Cancer Hospital, Chengdu 610041, China)

机构地区：[1]四川省肿瘤医院PET/CT中心,成都610041

出　　处：《国际放射医学核医学杂志》2019年第4期381-385,共5页International Journal of Radiation Medicine and Nuclear Medicine

摘　　要：笔者报道了一例18F-FDG联合18F-胸腺嘧啶脱氧核苷(18F-FLT)诊断原发性高分化肝癌的显像病例,从临床症状、实验室检查、影像学等方面分析该病特点,阐述了PET/CT在肝脏疾病诊断中的优势,同时指出18F-FDG在肝癌诊断中的不足,并通过文献回顾了18F-FLT、11C-乙酸盐在肝癌中的应用。不同显像剂的联合使用对肝脏占位的诊断具有重要价值。The author reported one case of 18F-FDG imaging combined with 18F fluorothymidine (18F-FLT) in the diagnosis of primary highly differentiated hepatocellular carcinoma. The characteristics of the disease were analyzed according to clinical symptoms, laboratory examinations, and radiology. The advantages of PET/CT in the diagnosis of liver diseases were expounded, and the deficiency of 18F-FDG in the diagnosis of liver cancer was indicated. The literature on the application of 18F-FLT 11C-acetate to hepatocellular carcinoma was reviewed. This study concluded that the combined use of different imaging agents is of great value in the diagnosis of liver-occupying lesions.

关 键 词：18F-FDG 疾病诊断 肝癌诊断 高分化 胸腺嘧啶脱氧核苷 PET/CT 肝脏占位 实验室检查 

分 类 号：R730.44[医药卫生—肿瘤] R735.7[医药卫生—临床医学]